UCB SA (EBR:UCB)
Belgium · Delayed Price · Currency is EUR 231.20
+5.00 (2.21%)
Apr 30, 2026, 5:39 PM CET
UCB SA Employees
UCB SA had 9,765 employees as of December 31, 2025. The number of employees increased by 713 or 7.88% compared to the previous year.
Employees
9,765
Change (1Y)
713
Growth (1Y)
7.88%
Revenue / Employee
€792,729
Profits / Employee
€159,549
Market Cap
44.01B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 9,765 | 713 | 7.88% | 9,765 | 0 |
| Dec 31, 2024 | 9,052 | -31 | -0.34% | 9,052 | 0 |
| Dec 31, 2023 | 9,083 | 380 | 4.37% | 8,450 | 633 |
| Dec 31, 2022 | 8,703 | 142 | 1.66% | 8,108 | 595 |
| Dec 31, 2021 | 8,561 | 190 | 2.27% | 8,006 | 555 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| argenx SE | 1,863 |
| European Medical Solutions | 123 |
| Onward Medical | 103 |
| Hyloris Pharmaceuticals | 50 |
| Oxurion NV | 11 |
| BioSenic | 7 |
| Celyad Oncology | 5 |
UCB SA News
- 2 months ago - Belgium's UCB in autoimmune drug deal with Antengene - Reuters
- 6 months ago - U.S. FDA approves KYGEVVI® (doxecitine and doxribtimine), the first and only treatment for adults and children living with thymidine kinase 2 deficiency (TK2d) - PRNewsWire